Mature DC membrane markers were analyzed by flow cytometry, and Mo-DCs obtained from breast cancer patients showed less HLA-DR, CD11c CD86, CD80, and CCR7 expressions when compared to Mo-DCs from healthy donors (Figure 1(a)). The gene discussed is CD86; the disease is breast cancer.